Birmingham secures $44 million in federal Tech Hub grants

Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company has ...
No specific initiatives on AI in healthcare are in sight but the inevitable impact of this technology will guide EU ...
AI is merely one facet of a sweeping technological change underway, and companies that fail to recognize the importance of ...
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) today announced the launch of its AI-powered pipeline of both optimized and new therapeutics, a system set ...
The AI-designed proteins neutralized lethal 3FTx toxins found in snake venom, which are often the reason that traditional ...
The U.S. Commerce Department is imposing new export controls on biotechnology equipment due to national security concerns ...
We recently compiled a list of the Why These 24 Stocks Are Skyrocketing. In this article, we are going to take a look at ...
Following these transactions, Schneider's direct ownership in Ionis Pharmaceuticals (NASDAQ:IONS) stands at 58,508 shares.